Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-EN
Language French English
Date Updated 2018-08-24 2018-08-24
Drug Identification Number 02231544 02231544
Brand name PMS-CARBAMAZEPINE-CR PMS-CARBAMAZEPINE-CR
Common or Proper name CARBAMAZEPINE -CR CARBAMAZEPINE -CR
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients CARBAMAZEPINE CARBAMAZEPINE
Strength(s) 400MG 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-05-15 2018-05-15
Actual discontinuation date
Remaining supply date 2018-05-15 2018-05-15
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments DISCONTINUED DISCONTINUED
Health Canada comments